ProPhase Labs Nears Settlement on $150M in Unpaid COVID-19 Testing Claims
Event summary
- ProPhase Labs is in advanced settlement talks with ~50 of 250+ insurance payors over $150M in unpaid or underpaid COVID-19 testing claims.
- First settlements expected within 30-90 days, potentially boosting near-term liquidity.
- Crown Medical estimates net recoveries could exceed $50M after fees and legal costs.
- Chapter 11 proceedings for lab subsidiaries aim to streamline recovery efforts and protect parent company.
The big picture
ProPhase's push to recover COVID-era receivables reflects broader industry challenges with payor delays and denials. The $150M in disputed claims highlights systemic payment practices during the pandemic, while the Chapter 11 strategy underscores the tension between aggressive recovery efforts and operational continuity. Success here could set a precedent for other labs facing similar receivables issues.
What we're watching
- Recovery Timing
- Whether the pace of settlements meets ProPhase's liquidity needs for restructuring.
- Claim Validity
- How courts and payors assess the legitimacy of disputed COVID-19 testing claims.
- Parent Company Protection
- The effectiveness of Chapter 11 in insulating ProPhase Labs from subsidiary liabilities.
Related topics